Related Experiment Video

Updated: Jul 14, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

A new calcineurin inhibition domain in Cabin1

Hyonchol Jang1, Eun-Jung Cho, Hong-Duk Youn

  • 1Department of Biochemistry and Molecular Biology, Cancer Research Institute, Interdisciplinary Program in Genetic Engineering, Seoul National University College of Medicine, 28 Yongon-dong, Chongro-gu, Seoul 110-799, Republic of Korea.

Biochemical and Biophysical Research Communications
|May 29, 2007
PubMed

Insights

Cabin1, a calcineurin binding protein 1, has a second binding site that inhibits calcineurin (CN) activity. This finding explains why Cabin1DeltaC T cells show no defect in CN-mediated signaling pathways.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Calcineurin (CN) is a calcium-activated phosphatase crucial for T cell activation.
  • Cabin1 (calcineurin binding protein 1) binds CN via its C-terminus, inhibiting its activity.
  • Previous studies showed no CN activity increase in Cabin1DeltaC T cells lacking the C-terminal binding region.

Purpose of the Study:

  • To identify additional calcineurin binding domains within Cabin1.
  • To investigate the functional significance of these novel binding sites.
  • To explain discrepancies in previous findings regarding Cabin1's role in CN signaling.

Main Methods:

  • Expression and purification of Cabin1 (701-900) peptide.
  • In vitro assays for calcineurin-mediated dephosphorylation.
  • Analysis of NFAT nuclear import.
  • Measurement of IL-2 production in response to PMA/ionomycin stimulation.

Main Results:

  • Cabin1 contains an additional calcineurin binding domain within amino acid residues 701-900.
  • The Cabin1 (701-900) peptide effectively blocked CN-mediated dephosphorylation.
  • This peptide also inhibited NFAT nuclear import and subsequent IL-2 production.
  • These results provide a molecular explanation for the lack of observed defects in Cabin1DeltaC T cells.

Conclusions:

  • Cabin1 possesses a second, functionally relevant calcineurin binding domain.
  • This domain contributes to the regulation of CN signaling, including NFAT dephosphorylation and IL-2 production.
  • The presence of this additional binding site clarifies previous observations in Cabin1-deficient T cells.

More Related Videos

Optimized Analysis of Proteins from Xenopus Oocytes and Embryos by Immunoblotting09:32

Optimized Analysis of Proteins from Xenopus Oocytes and Embryos by Immunoblotting

Published on: September 19, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Structure of Cadherins01:25

Structure of Cadherins

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This diversity of cadherins...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...